In multivariate analysis, tumor size decline ratio (OR=0.002; 95% CI: 0.000–0.117; p=0.002) and AFP decline ratio (OR=0.240; 95% CI: 0.067–0.862; p=0.029) during conversion therapy independently predicted a lower recurrence risk. The gene discussed is AFP; the disease is neoplasm.